Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up

JACC: Cardiovascular Interventions

Volumn 4, Issue 7, 2011, Pages 789-799

  Gomez Lara, Josep ^a   Brugaletta, Salvatore ^a   Farooq, Vasim ^a   Van Geuns, Robert Jan ^a   De Bruyne, Bernard ^b   Windecker, Stephan ^c   McClean, Dougal ^d   Thuesen, Leif ^e   Dudek, Dariusz ^f   Koolen, Jacques ^g   Whitbourn, Robert ^h   Smits, Pieter C ⁱ   Chevalier, Bernard ^j   Morel, Marie Angle ^k   Dorange, Cécile ^l   Veldhof, Susan ^l   Rapoza, Richard ^l   Garcia Garcia, Hector M ^a,k   Ormiston, John A ^m   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIOVASCULAR CENTER   (Belgium)

^c BERN UNIVERSITY HOSPITAL   (Switzerland)

^d CHRISTCHURCH HOSPITAL   (New Zealand)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f JAGIELLONIAN UNIVERSITY   (Poland)

^g CATHARINA HOSPITAL   (Netherlands)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ Maasstad Hospital Rotterdam   (Netherlands)

^j Institut Cardio vasculaire Paris Sud   (France)

^k CARDIALYSIS   (Netherlands)

^l ABBOTT VASCULAR   (United States)

^m AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

bioresorbable vascular scaffolds (BVS); coronary geometry; metallic platform stent (MPS)

Indexed keywords

EVEROLIMUS; TISSUE SCAFFOLD;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BIODEGRADABLE IMPLANT; BLOOD VESSEL PARAMETERS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DIASTOLE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GEOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SHEAR STRESS; SYSTOLE; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; STENTS; TIME FACTORS; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 79960592286     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.04.009     Document Type: Article

References (26)

1. A.M. Malek, S.L. Alper, and S. Izumo Hemodynamic shear stress and its role in atherosclerosis JAMA 282 1999 2035 2042
2. T. Asakura, and T. Karino Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries Circ Res 66 1990 1045 1066 (Pubitemid 20126435)
3. J.J. Wentzel, E. Janssen, and J. Vos Extension of increased atherosclerotic wall thickness into high shear stress regions is associated with loss of compensatory remodeling Circulation 108 2003 17 23 (Pubitemid 36859014)
4. K.C. Koskinas, C.L. Feldman, and Y.S. Chatzizisis Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in vivo intravascular ultrasound study Circulation 121 2010 2092 2101
5. J.F. LaDisa Jr., I. Guler, and L.E. Olson Three-dimensional computational fluid dynamics modeling of alterations in coronary wall shear stress produced by stent implantation Ann Biomed Eng 31 2003 972 980
6. J.J. Wentzel, R. Krams, and J.C. Schuurbiers Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries Circulation 103 2001 1740 1745 (Pubitemid 32291410)
7. M.I. Papafaklis, C.V. Bourantas, and P.E. Theodorakis The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans J Am Coll Cardiol Intv 3 2010 1181 1189
8. M. Gyongyosi, P. Yang, A. Khorsand, D. Glogar Austrian Wiktor Stent Study Group and European Paragon Stent Investigators Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events J Am Coll Cardiol 35 2000 1580 1589 (Pubitemid 30307504)
9. P.S. Phillips, F. Alfonso, and J. Segovia Effects of Palmaz-Schatz stents on angled coronary arteries Am J Cardiol 79 1997 191 193 (Pubitemid 127673710)
10. Y. Fukuda, K. Shirai, and S. Miura The impact of angulated lesions on angiographic late loss in patients with drug-eluting stent implantation J Cardiol 53 2009 396 401
11. S. Rathore, M. Terashima, and O. Katoh Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients EuroIntervention 5 2009 349 354
12. K.W. Park, C.H. Kim, and H.Y. Lee Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents Am Heart J 159 2010 446 453.e3
13. W. Schmidt, P. Lanzer, P. Behrens, L.D. Topoleski, and K.P. Schmitz A comparison of the mechanical performance characteristics of seven drug-eluting stent systems Catheter Cardiovasc Interv 73 2009 350 360
14. J. Gomez-Lara, H.M. Garcia-Garcia, and Y. Onuma A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents J Am Coll Cardiol Intv 3 2010 1190 1198
15. J. Oberhauser, S. Hossainy, and R. Rapoza Design principles and performance of bioresorbable polymeric vascular scaffolds EuroIntervention 5 Suppl F 2009 F15 F22
16. Y. Onuma, P.W. Serruys, and L.E. Perkins Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
17. P.W. Serruys, Y. Onuma, and J.A. Ormiston Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
18. P.W. Serruys, A.T. Ong, and J.J. Piek A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial EuroIntervention 1 2005 58 65
19. P.W. Serruys, P. Ruygrok, and J. Neuzner A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
20. J. Fleiss The Design and Analysis of Clinical Experiments 1986 John Wiley & Sons New York, NY
21. J.A. Ormiston, P.W. Serruys, and E. Regar A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial Lancet 371 2008 899 907 (Pubitemid 351384734)
22. S. Nishio, K. Kosuga, and M. Okada Long Term (>10 Years) Clinical Outcomes of the First-In-Man Biodegradable Poly-L-Lactic Acid Coronary Stents Presented at: EuroPCR 2010 Paris, France
23. F.J. Gijsen, R.M. Oortman, and J.J. Wentzel Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries Am J Cardiol 92 2003 1325 1328 (Pubitemid 37431144)
24. B.E. Claessen, M.A. Beijk, and V. Legrand Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial Circ Cardiovasc Interv 2 2009 339 347
25. S. Tu, G. Koning, W. Jukema, and H. Reiber Assessment of obstruction length and optimal viewing angle from biplane X-ray angiograms Int J Cardiovasc Imaging 26 2010 5 17
26. N. Bruining, S. Tanimoto, and M. Otsuka Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2-and 3D-QCA, QCU and QMSCT-CA EuroIntervention 4 2008 285 291